Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 2 boards, counting each seat separately. Longest: Unicycive Therapeutics Inc., 3 years.
Unicycive Therapeutics Inc.
Director
Geron Corporation
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 25, 2025 | Unicycive Therapeutics Inc. | Derivative conversion | +652,900 | — | — |
| Feb 18, 2025 | Unicycive Therapeutics Inc. | Derivative conversion | +1,400,000 | — | — |
| Oct 9, 2024 | Unicycive Therapeutics Inc. | Derivative conversion | +5,500,000 | — | — |
| Dec 29, 2023 | Geron Corporation | Grant or award | +1,970 | — | — |
| Jul 11, 2023 | Unicycive Therapeutics Inc. | Derivative conversion | +3,470,152 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.